BRIEF published on 04/24/2026 at 11:35, 6 months 6 days ago Sartorius AG Extends CFO Florian Funck's Tenure Executive Board Sartorius AG Biopharmaceutical Industry Financial Leadership Florian Funck
PRESS RELEASE published on 04/24/2026 at 11:30, 6 months 6 days ago Sartorius AG Supervisory Board extends appointment of board member Florian Funck Sartorius AG extends CFO Florian Funck's term on the Executive Board until 2032. Learn more about Funck's background and Sartorius AG's financial calendar and divisions CFO Executive Board Supervisory Board Sartorius AG Florian Funck
BRIEF published on 04/23/2026 at 07:05, 6 months 7 days ago Sartorius Reports Strong Start to 2026 with Revenue Growth Revenue Growth Profit Margin Bioprocess Solutions 2026 Guidance Lab Division
PRESS RELEASE published on 04/23/2026 at 07:00, 6 months 7 days ago Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin Sartorius AG marks positive start to 2026 with 7.5% sales revenue growth and 29.7% profit margin. Full-year guidance confirmed. Bioprocess Solutions grows by 8.1% Sartorius AG Full-year Guidance Profit Margin Bioprocess Solutions Sales Revenue Growth
BRIEF published on 03/26/2026 at 16:25, 7 months 5 days ago Sartorius AG Extends René Fáber's Board Appointment Executive Board Sartorius AG Bioprocess Solutions Appointment Extension René Fáber
PRESS RELEASE published on 03/26/2026 at 16:20, 7 months 5 days ago Sartorius AG Supervisory Board extends appointment of board member René Fáber Sartorius AG extends Dr. René Fáber's appointment on the Board until Dec 31, 2031, reinforcing the Bioprocess Solutions Division leadership. Learn more about Sartorius AG's latest decision here Supervisory Board Sartorius AG Appointment Extension René Fáber Bioprocess Solutions Division
BRIEF published on 03/26/2026 at 15:28, 7 months 5 days ago Sartorius AG Concludes Annual General Meeting with Key Resolutions Financial Results Annual General Meeting Life Sciences Sartorius Dividends
PRESS RELEASE published on 03/26/2026 at 15:23, 7 months 5 days ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG's Annual General Meeting results approved dividend of 0.74 euros per preference share and 0.73 euros per ordinary share. Next financial reports in April, July, and October 2026 Annual General Meeting Dividend Financial Reports Biopharmaceutical Sartorius AG
BRIEF published on 03/17/2026 at 07:04, 7 months 14 days ago Sartorius Intensifies Biopharma Strategy with Ambitious Growth Targets Operational Efficiency Growth Targets Bioprocess Solutions Sales Revenue Growth Biopharma Strategy
PRESS RELEASE published on 03/17/2026 at 06:59, 7 months 14 days ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets at Capital Markets Day in Göttingen, Germany Sartorius Strategy Capital Markets Day Growth Targets Biopharma Focus
Published on 10/30/2026 at 23:35, 1 day ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 5 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 8 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 7 hours 54 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 1 hour ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 5 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 1 hour ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 12 hours ago Capital increase through exercise of subscription rights
